Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Transdermal System vs Oxycodone/Acetaminophen in Osteoarthritis Pain
NCT00315848Phase 3Completed
- Sponsor
- Purdue Pharma
- Start
- Nov 1996
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of buprenorphine in osteoarthritis (OA) (3 arms), sponsored by Purdue Pharma. Primary endpoint: Pain on average and pain right now scores at Day 60. Started Nov 1996; status: completed.
02
Drugs
buprenorphine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00315848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315848.